Log in to save to my catalogue

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2628901840

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

About this item

Full title

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

Publisher

New York: Springer US

Journal title

Neurochemical research, 2022-03, Vol.47 (3), p.552-573

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Neurodegenerative disorders are distinguished by the gradual deterioration of the nervous system’s structure and function due to oxidative stress, mitochondrial dysfunction, protein misfolding, excitotoxicity, and neuroinflammation. Among these NDs, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis ch...

Alternative Titles

Full title

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2628901840

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2628901840

Other Identifiers

ISSN

0364-3190

E-ISSN

1573-6903

DOI

10.1007/s11064-021-03488-7

How to access this item